IMPACT THERAP-B (07630.HK), a biotechnology company at the commercialization stage, kicked off its IPO today (5th), which will last until this Friday (8th).The company plans to issue 41.977 million H-shares, with 10% allocated to the Hong Kong public offering. With an offer price of HKD19.75-21.75 per share, this IPO aims to raise up to HKD910 million. The entry fee for a board lot of 200 shares is HKD4,393.9. The listing is scheduled for May 13.Related News HSBC Research Cites Experts: TENCENT (00700.HK) and BABA-W (09988.HK) Benefit from Ecosystem AdvantagesIMPACT THERAP-B has introduced a group of cornerstone investors, including TENCENT (00700.HK) +5.400 (+1.181%) Short selling $1.73B; Ratio 14.111% , LAV, and WWHCP. They have subscribed for USD35.74 million worth of shares.(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-13 16:25.)
AASTOCKS Financial News